Cargando…

Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C

A 20-year-old indigenous Australian male was admitted to the intensive care unit with fulminant hepatic failure secondary to intravenous use of buprenorphine, which had been prescribed sublingually for opioid dependence. Intravenous buprenorphine-induced hepatitis is well recognized, however, life-t...

Descripción completa

Detalles Bibliográficos
Autores principales: French, Janine, Mujumdar, Avik, Angus, Peter, Gow, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551330/
https://www.ncbi.nlm.nih.gov/pubmed/26331017
http://dx.doi.org/10.1002/ccr3.314
_version_ 1782387560078639104
author French, Janine
Mujumdar, Avik
Angus, Peter
Gow, Paul
author_facet French, Janine
Mujumdar, Avik
Angus, Peter
Gow, Paul
author_sort French, Janine
collection PubMed
description A 20-year-old indigenous Australian male was admitted to the intensive care unit with fulminant hepatic failure secondary to intravenous use of buprenorphine, which had been prescribed sublingually for opioid dependence. Intravenous buprenorphine-induced hepatitis is well recognized, however, life-threatening fulminant hepatic failure has not previously been reported.
format Online
Article
Text
id pubmed-4551330
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45513302015-09-01 Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C French, Janine Mujumdar, Avik Angus, Peter Gow, Paul Clin Case Rep Case Reports A 20-year-old indigenous Australian male was admitted to the intensive care unit with fulminant hepatic failure secondary to intravenous use of buprenorphine, which had been prescribed sublingually for opioid dependence. Intravenous buprenorphine-induced hepatitis is well recognized, however, life-threatening fulminant hepatic failure has not previously been reported. John Wiley & Sons, Ltd 2015-08 2015-06-30 /pmc/articles/PMC4551330/ /pubmed/26331017 http://dx.doi.org/10.1002/ccr3.314 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
French, Janine
Mujumdar, Avik
Angus, Peter
Gow, Paul
Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title_full Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title_fullStr Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title_full_unstemmed Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title_short Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
title_sort fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis c
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551330/
https://www.ncbi.nlm.nih.gov/pubmed/26331017
http://dx.doi.org/10.1002/ccr3.314
work_keys_str_mv AT frenchjanine fulminanthepaticfailureafterintravenousinjectionofsublingualbuprenorphineinapatientwithhepatitisc
AT mujumdaravik fulminanthepaticfailureafterintravenousinjectionofsublingualbuprenorphineinapatientwithhepatitisc
AT anguspeter fulminanthepaticfailureafterintravenousinjectionofsublingualbuprenorphineinapatientwithhepatitisc
AT gowpaul fulminanthepaticfailureafterintravenousinjectionofsublingualbuprenorphineinapatientwithhepatitisc